Related references
Note: Only part of the references are listed.Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
Sara Haggblad Sahlberg et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Ines Marmol et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing
Jean-Marc Rey et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study
Mayank Jauhri et al.
TUMOR BIOLOGY (2017)
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers A Secondary Analysis of 2 Randomized Clinical Trials
Frank A. Sinicrope et al.
JAMA ONCOLOGY (2017)
The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
Daeyoun David Won et al.
BMC CANCER (2017)
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2017)
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis
Javier Garde Noguera et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
Izuma Nakayama et al.
BMC CANCER (2017)
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
Inger Marie Loes et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern
Humaid O. Al-Shamsi et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
Bastiaan B. J. Tops et al.
BMC CANCER (2015)
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
Luisa Foltran et al.
FUTURE ONCOLOGY (2015)
The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment
Jeroen R. Dijkstra et al.
VIRCHOWS ARCHIV (2015)
Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
Jing Zhang et al.
SCIENTIFIC REPORTS (2015)
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies
Nguyen H. Tran et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
Sun Tian et al.
GUT (2013)
Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
Nicola Normanno et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Personalizing Oncology: Perspectives and Prospects
John Mendelsohn
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
Andrew G. Hadd et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas
Maria E. Arcila et al.
CLINICAL CANCER RESEARCH (2012)
Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer
Lina Ohlsson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Amanda K. Arrington et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Magdalena Cizkova et al.
BREAST CANCER RESEARCH (2012)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
AKT1E17K in human solid tumours
F. E. Bleeker et al.
ONCOGENE (2008)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford et al.
BRITISH JOURNAL OF CANCER (2004)
Share Paper
